Related Experiment Video

Updated: Jul 16, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Age-related difference in immune responses to respiratory syncytial virus infection in young children

Hai Lee Chung1, Hye Jin Park, So Yeon Kim

  • 1Department of Pediatrics, School of Medicine, Catholic University of Taegu, Taegu, Korea. hlchung@cu.ac.kr

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|March 7, 2007
PubMed

Insights

Immune responses to respiratory syncytial virus (RSV) infection differ significantly with age in infants. Older infants show heightened cytokine responses, suggesting age-related immune development impacts RSV bronchiolitis severity.

Area of Science:

  • Immunology
  • Pediatrics
  • Virology

Background:

  • The immune system undergoes significant development during infancy.
  • Respiratory syncytial virus (RSV) bronchiolitis is a common infection in young children.
  • Understanding age-related immune responses to RSV is crucial for managing bronchiolitis.

Purpose of the Study:

  • To investigate age-related differences in cytokine responses to RSV infection.
  • To compare immune responses between infants under 6 months and children over 12 months.
  • To analyze cytokine profiles in relation to RSV bronchiolitis severity.

Main Methods:

  • Forty-five children under 24 months with acute RSV bronchiolitis were enrolled.
  • Patients were divided into two age groups: < or =6 months and > or =12 months.
  • Serum cytokine levels (IFN-gamma, IL-10, IL-4, IL-13) were measured using ELISA and compared to age-matched controls.

Main Results:

  • Infants < or =6 months had higher baseline IFN-gamma and IL-13 than older controls (> or =12 months).
  • RSV infection in children > or =12 months was associated with significantly higher IFN-gamma, IL-10, and IL-13 levels compared to controls.
  • RSV infection in infants < or =6 months showed a trend toward lower IFN-gamma and no significant difference in IL-10 or IL-13 compared to controls.

Conclusions:

  • Significant age-related differences exist in cytokine responses to RSV infection during early life.
  • The developmental stage of the immune system influences the cytokine profile during RSV bronchiolitis.
  • These findings suggest age-specific immune responses should be considered in managing RSV bronchiolitis.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...